Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

<ul><li>Instead of allowing vaccine makers to charge customers different prices for the same vaccine, the government could offer subsidy for those who need it the most via direct cash transfer.</li><li>Allowing different prices offers an incentive to move the stock of vaccines to the buyers who pay more i.e. private hospitals.</li><li>That may leave a lot of poorer Indians waiting in queues for a long time to get their share of the jabs.</li><li>Even with direct cash transfer, there may be a need to cap prices and to declare hoarding as a criminal act to ensure that the kind of leakage seen in ration shops is not replicated in vaccines as well. </li><li>There are arguments against direct benefit transfer as well. </li></ul>The new prices for COVID-19 vaccine, Covishield, has triggered a debate in India. Some argue that the prices are too high for everyone to be able to afford, and some say that it should be free for all and the government should bear the cost. The government already has a lot of expenses piling up as it manages the pandemic, and hence, there are also those who see merit in arguing that those who can pay for the vaccine, must pay for it. However, there is a problem with letting private and for-profit companies charge different prices from different customers. These are the prices fixed by Serum Institute of India (SII) for the Covishield vaccine: <table style="border-width: initial; border-style: none; table-layout: fixed; width: 468pt;"></colgroup><tbody><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">If the vaccine is sold to… </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Price per dose </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Central government </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹150 </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">State government </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹400 </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Private hospitals </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹600 </td></tr></tbody></table> India is a developing country with millions of poor people with poor access to, and little money to spare for, healthcare. By allowing vaccine makers to choose the pricing based on who is buying the vaccine, the government may give the producer an incentive to direct more vaccines to the more expensive private hospitals, whereas a majority of the country still depends on state-run facilities. “Pricing should be uniform. Both the central and state governments should pay the same price for the vaccine. The government should also cap the price of the vaccine sold at private hospitals. Even the administrative charges should be capped. Otherwise a family of four may end up paying a lot for vaccination,” Doctor Sanjeev Bagai, Chairman and Managing Director of the New Delhi-based Nephron clinic told Business Insider. “Direct benefit transfer is also an option. And the cost of vaccination should be covered by all insurance companies,” Bagai added. <div type="image" title="Kolkata:Beneficiaries stands in a queue outside a health centre to receive a dos..." msid="82200586" hostid="261" caption="&amp;lt;p&amp;gt;Beneficiaries stands in a queue outside a health centre to receive a dose of Covid-19 vaccine, amid surge in coronavirus cases, in Kolkata.Photo/Swapan Mahapatra)(&amp;lt;/p&amp;gt;"></div> The case for direct reimbursement for the cost of vaccine One may argue that there are covenants in place to ensure that the company sends an agreed amount of supply to government facilities. However, decades of similar policy experiments have taught us that such agreements are inefficient and provide a fertile ground for corrupt practices. The failure of such mechanisms gave birth to the idea of Direct Benefit Transfer (DBT). It could be deployed here as well, given that patients coming in for vaccination are already being asked to submit their Aadhaar (unique identity number) details. Vaccine makers should charge the same price from all customers. Those who access it via government agencies, or any other filter as may be applicable, should be allowed to get the subsidy reimbursed to their bank account. This has been effectively used in transferring other subsidies like the ones for cooking gas and fertilisers. The government’s own estimate is that it has saved over ₹1.78 lakh crore ($25 billion) in subsidy leakage because of DBT. The argument against direct benefit transfer There are two arguments here against direct benefit transfer. One from R Ramakumar, Professor at Tata Institute of Social Sciences, who wants vaccines to be free for all as it is in countries like US, UK and China. The other argument is from Dr Arvind Virmani, an economist and the former Chief Economic Advisor to the government of India, who wants drug prices to be decontrolled totally and do a direct cash transfer on a larger scale and not limit it to vaccines alone. “Supply chain has to be developed. It can’t be done overnight. The data on production and sale of vaccines is transparently available from the producers, for the government, Astrazeneca and others to see. To introduce DBT now, it would mean taking out funding from other budgeted activities like infrastructure construction. Right now, vaccination is working smoothly. Don’t disrupt it,” he told Business Insider. Aside from the fact this may add a bureaucratic layer, Ramakumar’s contention is that by allowing state-run facilities to charge less, and private hospitals to charge more, there is an incentive of corruption in distribution. India already has decades of bad experience. from the public distribution system a.k.a the ration shops, where the subsidised stock is moved out to be sold at a higher price. A cap on prices, and a crackdown on hoarders by making it a criminal act, may be necessary to counter this, even with reimbursement of the vaccine cost via direct transfer to bank accounts. Virmani’s take is that there is a case to be made for both deregulating drug prices, as well as direct cash transfer for a variety of reasons, in India but that can’t be debated in the middle of a pandemic. “All drugs are controlled. We should be discussing decontrol of drugs. That’s not the problem right now. For the last 12 months, I have been saying you can create a direct cash transfer in 4 months. It should still be considered,” he added. SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/india/news/while-covid-19-is-making-millions-gasp-for-breath-in-india-state-administrations-are-trying-to-hoard-oxygen/articleshow/82199390.cms">While COVID-19 is making millions gasp for breath in India, state administrations are trying to hoard oxygen</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/business/auto/news/covid-19-lockdowns-and-curfews-affecting-worlds-fourth-largest-automobile-market/articleshow/82195326.cms">There is a virtual lockdown in the world’s fourth largest automobile market</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/business/startups/news/revolut-appoints-former-flipkart-exec-paroma-chatterjee-as-its-india-ceo/articleshow/82181199.cms">Revolut starts India operations, appoints former Lendingkart, Flipkart executive Paroma Chatterjee as CEO</a>

If the COVID-19 vaccine prices are too high for some, then why not use direct benefit transfer

The COVID-19 vaccination drive has already started in countries like the US and UK. India recently approved two vaccines for use in the country, and the government has also <a href="https://www.businessinsider.in/india/news/india-to-conduct-nationwide-covid-19-vaccine-dry-run-on-january-2/articleshow/80044250.cms">conducted</a> a nation-wide dry run. To properly implement the Covid-19 vaccination drive in the country, the government has introduced the Co-WIN platform. The government will soon introduce the <keyword id="10402099" type="UNKNOWN" weightage="20" keywordseo="co-win-app">Co-WIN app</keyword> that will allow users to register for the COVID-19 vaccination. The Co-WIN app will feature five modules - Administrator module, Registration module, Vaccination module, Beneficiary Acknowledgement module, and Report module. What is the status of COVID-19 vaccination in India? The government has approved [link to our copy] Oxford Institute's Covishield and Bharat Biotech's Covaxin vaccines in the country. The vaccines will first be provided for healthcare workers and frontline workers. After this, the vaccines will be available for citizens who are above 50 years of age and then the remainder of the population. How to download the Co-WIN app? The Co-WIN app is currently not available for download. Once it has been launched, it will be available on the Google Play Store and the Apple App Store. How to register for the COVID-19 vaccine? Once the Co-WIN app is launched, people will be able to register for the COVID-19 vaccine. Citizens will be able to use the Registration module of the Co-WIN app to register for the vaccine. The app will offer three registration options – <ul><li>self-registration </li><li>individual registration </li><li>bulk upload </li></ul> The bulk upload will likely be used by surveyors and district administrators for beneficiary registration. What are the documents required for COVID-19 vaccine registration? Users registering for the COVID-19 vaccine will be required to upload a photo ID. The following identity proofs will be accepted in the Co-WIN app: <ul><li>Aadhaar Card </li><li>Driving License </li><li>MNREGA Job Card </li><li>PAN Card </li><li>Passport </li><li>Pension Document </li><li>Voter ID </li><li>Health Insurance Smart Card </li><li>Passbook </li></ul>What will be the cost of the COVID-19 vaccine? Union Health Minister Harsh Vardhan has said that the vaccine will be available free of cost for the priority groups in the first phase. Details on vaccination costs for the rest of the population are still being finalised. According to the Serum Institute of India, the vaccine will only <a href="https://www.businessinsider.in/science/health/news/serums-covishield-vaccine-nears-approval-the-expert-panel-recommends-it-for-emergency-use/articleshow/80061585.cms">cost</a> the government $3 per dose. Pfizer, on the other hand, is selling its vaccine at $37 per dose. SEE ALSO: <a href="https://www.businessinsider.in/india/news/siis-oxford-astra-zeneca-covid-19-vaccine-to-cost-3-4-to-indian-government-price-likely-to-be-double-in-private-markets/articleshow/80098173.cms">SII's Oxford-Astra Zeneca COVID-19 vaccine to cost $3-4 to Indian government, price likely to be double in private markets</a> <a href="https://www.businessinsider.in/science/health/news/india-will-soon-begin-worlds-biggest-covid-19-vaccination-programme-pm-modi/articleshow/80094307.cms">India will soon begin world's biggest COVID-19 vaccination programme: PM Modi</a> <a href="https://www.businessinsider.in/india/news/bharat-biotech-gets-permission-to-manufacture-covid-19-vaccine-covaxin-for-sale/articleshow/80084392.cms">Bharat Biotech gets permission to manufacture covid 19 vaccine 'covaxin' for sale</a>

Co-WIN app to be used for COVID-19 vaccine — how to register, documents required, and everything you need to know

<ul class="summary-list"><li>The US is getting closer to having an effective <keyword id="8763838" type="UNKNOWN" weightage="60" keywordseo="covid-19">COVID-19</keyword> <keyword id="24209" type="PERSON" weightage="60" keywordseo="vaccine">vaccine</keyword>, after drug company <keyword id="44612" type="CITY" weightage="60" keywordseo="Pfizer">Pfizer</keyword> said Monday that its experimental vaccine is 90% effective at preventing the disease caused by coronavirus.</li><li>A vaccine won't be effective if most people don't take it, and that will depend on whether people can afford it. </li><li>The US government has already agreed to buy hundreds of millions of doses of future COVID-19 vaccines from drugmakers. President-elect Joe Biden has also said he will guarantee free vaccines to every American.</li><li>Congress in March called on COVID-19 vaccines to be free for all Americans. Federal regulation in recent weeks has implemented that legislation and requires <keyword id="6467162" type="ORGANIZATION" weightage="60" keywordseo="medicare">Medicare</keyword>, <keyword id="191993" type="ORGANIZATION" weightage="60" keywordseo="Medicaid">Medicaid</keyword> and private <keyword id="70387" type="ORGANIZATION" weightage="60" keywordseo="insurers">insurers</keyword> to cover the vaccine at no cost to members.</li><li>A relief fund for <keyword id="6354525" type="UNKNOWN" weightage="100" keywordseo="healthcare">healthcare</keyword> providers will help to cover the cost of the vaccine for people who don't have insurance.</li></ul>The US just got much closer to having an effective vaccine to battle the COVID-19 pandemic, after drug company Pfizer said Monday that its <a href="https://www.businessinsider.com/pfizer-coronavirus-vaccine-success-plans-for-emergency-approval-fda-2020-9">experimental coronavirus vaccine proved 90% effective</a> at preventing the disease.But a vaccine won't work unless most people take it, and that will hinge largely on whether people can afford it. The federal government has taken steps in recent weeks to ensure that many Americans will be able to get the vaccine for free.Congress passed legislation in March that called for free COVID-19 vaccines for all Americans. In October, the Centers for Medicare and Medicaid Services said Medicare, Medicaid and most private health insurers will be required to provide the vaccines at no cost to their members. The US government will pay for those vaccines.As part of Operation Warp Speed, the government has already <a href="https://www.businessinsider.com/us-government-to-buy-100-million-doses-moderna-covid-vaccine-2020-8">agreed to buy hundreds of millions</a> of COVID-19 vaccines from drug companies. In July, the government reached a deal with Pfizer to buy 100 million doses for $1.95 billion, and included an option to buy up to 500 million more doses.President-elect Joe Biden has also said he wants the <keyword id="8764262" type="UNKNOWN" weightage="60" keywordseo="covid">COVID</keyword> vaccine to be available for free. He will invest $25 million into a vaccine manufacturing and distribution plan that guarantee free vaccines to every American, <a href="https://buildbackbetter.com/priorities/covid-19/">according to his plan.</a><h2>A COVID-19 vaccine will likely be free for most insured people</h2>Medicare, which covers about <a href="https://www.cms.gov/research-statistics-data-systems/cms-fast-facts/cms-fast-facts-mobile-site">62 million people</a>, will cover a future vaccine that receives a greenlight from the U.S. Food and Drug Administration, either through an emergency use authorization or licensed under a Biologics License Application, CMS said in an interim final rule released in October.Seniors and other people covered by Medicare won't have to pay any cost-sharing, including deductibles or coinsurance, which is the percentage of cost people must pay after meeting a deductible, according to the rule. Medicaid programs, which cover <a href="https://www.cms.gov/research-statistics-data-systems/cms-fast-facts/cms-fast-facts-mobile-site">76.5 million people</a>, are also <a href="https://www.shvs.org/ensuring-access-to-the-covid-19-vaccine-for-adult-medicaid-enrollees-a-roadmap-for-states/">required to cover the cost of the vaccine</a> through the public health emergency.People with private health insurance through their jobs or the individual market also will be able to get a vaccine for free. About <a href="https://www.kff.org/report-section/ehbs-2020-summary-of-findings/">157 million people</a> receive coverage through their employers.The ACA requires most insurers and employers to cover preventive services, including vaccines, at no cost to the member. But that doesn't mean all vaccines.The Advisory Committee on Immunization Practices that's a part of the Centers for Disease Control and Prevention has to sign off on it, Sabrina Corlette, a Georgetown University research professor and expert on private insurance, told Business Insider. "If you are in health coverage that is covered by the Affordable Care Act—and that's a caveat because we know there are lots of people who may be in plans not subject to the ACA, like short-term plans—and a vaccine is recommended by this committee, health plans within 15 days have to cover it and they can't charge you a deductible or coinsurance or copayment for that vaccine," Corlette said.Usually, health insurers have up to two years after ACIP recommends a vaccine before they have to begin covering a vaccine. The March legislation, known as the CARES Act, sped up that timeline by requiring insurers to cover COVID-19 vaccines 15 days of the committee's recommendation.<h2>The cost of administering vaccines should be covered as well </h2>The CMS interim final rule in October went a step further to require health plans and insurers to cover both the COVID-19 vaccine and the administration of that vaccine for free, even if it is given by an out-of-network doctor. Those rules are effective immediately and last for as long as the public health emergency.When asked if it would cover a COVID-19 vaccine for free, large health insurer Aetna, which is owned by CVS Health, said it would provide the vaccine without cost-sharing for its members, consistent with the CARES Act and recent federal regulation. Other major health insurers did not respond by deadline.As for people who don't have insurance, the government will use the Cares Act Provider Relief Fund, which was established to help providers weather the pandemic, to cover their costs.

We're getting closer to an effective COVID-19 vaccine. Here's what it will cost to get a shot.

<ul><li>The Indian government is set to role out the second phase of <keyword id="10820295" type="UNKNOWN" weightage="20" keywordseo="covid-19-vaccination-from-march-1">COVID-19 vaccination from March 1</keyword>.</li><li><keyword id="20566" type="COMPANY" weightage="20" keywordseo="senior-citizens">Senior citizens</keyword> above the age of 60 years and those over 45 years old with comorbidities will be eligible for the vaccine. </li><li>The vaccine doses will be given free of cost at government hospitals and will also be available at private clinics, but the price tag for private distribution is yet to be decided.</li></ul>The Indian government announced today that COVID-19 vaccine doses for senior citizens will be available starting March 1. This includes anyone who is above 60 years of age and people above 45 years of age with comorbidities. “The COVID-19 vaccine will be available across 10,000 government facilities and many private hospitals,” said Union Minister Prakash Javadekar during the cabinet briefing. While the vaccine will be given free of cost at government hospitals, the cost of the vaccine at private hospitals is yet to be decided by the Health Ministry. According to Javadekar, the benchmark for this will be decided within the next two to three days after consulting with the vaccine manufacturers. This comes after the first phase of COVID-19 vaccine drive, which was <a href="https://www.businessinsider.in/science/health/news/covid-19-vaccination-in-india-health-ministry-releases-list-of-potential-side-effects/articleshow/80278217.cms">initiated on January 15</a>, has been completed. According to Javadekar, over 1.07 crore people were vaccinated during this time — most of them frontline workers. Among them, around 14 lakh have gotten the second dose as well. As the vaccination reaches out to the masses, the world’s largest vaccine maker Serum Institute of India (SII) has been asked to focus on India’s needs, tweeted its CEO Adar Poonawalla. <div type="twitter" handle="adarpoonawalla" handlename="Adar Poonawalla" image="http://pbs.twimg.com/profile_images/1302181254746509313/Kn1fTCv6_normal.jpg" favoritecount="28398" retweetcount="2609" status="Dear countries &amp; governments, as you await #COVISHIELD supplies, I humbly request you to please be patient,… https://t.co/tQQsGkPtVW" createdat="1613882072000" id="1363346341275967488"></div> Those opting for the COVID-19 vaccine will either receive SII’s Covishield or Bharat Biotech’s Covaxin. The potential, but mild, side effects of the vaccines include headache, fatigue, myalgia (pain in muscle), injection site tenderness, malaise (weakness), pyrexia, chills, arthralgia, and nausea, according to the <a href="https://www.businessinsider.in/science/health/news/covid-19-vaccination-in-india-health-ministry-releases-list-of-potential-side-effects/articleshow/80278217.cms">Health Ministry. </a> SEE ALSO: <a href="https://www.businessinsider.in/news/covid-19-vaccines-in-india-are-at-risk-of-expiring-while-anxious-senior-citizens-wait-for-their-turn/articleshow/81127178.cms">COVID-19 vaccines in India are at risk of expiring while anxious senior citizens wait for their turn</a> <a href="https://www.businessinsider.in/tech/enterprise/news/indian-government-wants-its-it-hardware-industry-to-be-as-globally-successful-as-tcs-hcl-tech-and-infosys-announces-pli-scheme-worth-7250-crore/articleshow/81189588.cms">Indian government wants its IT hardware industry to be as globally successful as TCS, HCL Tech and Infosys — announces PLI scheme worth ₹7,250 crore</a> <a href="https://www.businessinsider.in/stock-market/news/nse-halts-trading-after-data-glitches-stop-nifty50-and-bank-nifty-from-updating/articleshow/81186539.cms">India’s largest stock exchange halts trading after data glitches stop Nifty50 and Bank Nifty from updating</a>

COVID-19 vaccination for senior citizens to start from March 1 in India — will be free at government hospitals

<ul class="summary-list"><li>The University of Southern <keyword id="99644" type="ENTERTAINMENT" weightage="60" keywordseo="Mississippi">Mississippi</keyword> is giving students incentives to get vaccinated.</li><li>Vaccinated students will be randomly selected to win things like fall tuition and housing credits.</li><li>Mississippi has one of the country's lowest vaccination rates and is seeing a surge in <keyword id="8763838" type="UNKNOWN" weightage="60" keywordseo="covid-19">COVID-19</keyword>.</li></ul>The University of Southern Mississippi will pay some students in tuition and housing costs if they get vaccinated, the school said in a statement Thursday.The <a href="https://www.usm.edu/news/2021/release/vaccine-incentive-program.php">incentive program</a> is intended to encourage students to get the COVID-19 <keyword id="24209" type="PERSON" weightage="60" keywordseo="vaccine">vaccine</keyword>. Over the next 12 weeks, five vaccinated students will be randomly selected each week to receive rewards. The items students can win include Fall semester tuition, which costs $4,602; $2,000 in housing credits; and $1,000 in dining credits, among other things."The best way for our students to stay healthy, stay connected, and stay in class this fall is by getting a COVID-19 vaccine. I urge all of our students to do their part and get vaccinated for COVID-19 now, if they haven't already done so," Dr. Dee Dee Anderson, USM Vice President for Student Affairs, said in the announcement.Read more: <a href="https://www.businessinsider.com/delta-variant-dont-lockdown-mask-mandates-covid-vaccine-passports-unvaccinated-2021-7">Don't punish the vaccinated - make it harder to choose to be unvaccinated</a>Mississippi has one of the lowest vaccination rates of any state, with only 34.5% of its residents fully vaccinated, according to Centers of Disease Control and Prevention data compiled by the <a href="https://www.mayoclinic.org/coronavirus-covid-19/vaccine-tracker">Mayo Clinic</a>. Only Alabama has a smaller portion of its residents fully vaccinated.Mississippi is also seeing a surge in COVID-19 cases and hospitalizations as the Delta variant spreads. Some intensive care units in the state are near capacity, the <a href="https://www.clarionledger.com/story/news/2021/07/30/covid-19-delta-variant-not-leaving-soon-unless-more-vaccinated/5427600001/">Clarion Ledger</a> reported.Some states have offered incentives to getting the vaccine, including <a href="https://www.businessinsider.com/states-offering-cash-as-incentive-to-get-covid-19-vaccine-2021-5#ohio-is-offering-a-1-million-jackpot-to-five-vaccinated-adults-1">vaccine lotteries</a> in states like California and Ohio.President Joe Biden called on states and local governments this week to <a href="https://www.businessinsider.com/biden-pushes-local-governments-to-offer-100-vaccine-incentives-2021-7">pay people $100 to get inoculated</a>.

The University of Southern Mississippi is paying tuition and housing for some vaccinated students to encourage them to get the shot

<ul><li>The CEO of the Serum Institute of India (SII) Adar Poonawalla told CNBC-TV18 that a single dose of the COVID-19 vaccine being developed by the Oxford University and AstraZeneca would cost the government $3 — around ₹222. </li><li>For private individuals looking to procure the COVID-19 out of their own pocket, it will cost ₹1,000 for both doses. </li><li>He also revealed that the vaccine orders would first be opened to India and the World Health Organisation's COVAX before engaging in bilateral discussions with any other country. </li></ul>The success of the <a href="https://www.businessinsider.in/science/health/news/oxford-and-astrazeneca-covid-19-vaccine-is-70-effective-and-india-may-authorise-emergency-use-after-uk-nod/articleshow/79365393.cms">Oxford-AstraZeneca COVID-19 vaccine</a> means that it may soon be available in India. The CEO of Serum Institute of India (SII), the company conducting the clinical trials of the vaccine in India, told CNBC-TV18 that a single dose would cost the government $3 (around ₹222). Those looking to buy the vaccine out of their own pocket will have to pay ₹1,000, but for both doses. <div type="twitter" handle="CNBCTV18Live" handlename="CNBC-TV18" image="http://pbs.twimg.com/profile_images/633210816485965824/0cQi0eZS_normal.jpg" favoritecount="20" retweetcount="2" status="#CNBCTV18Exclusive | @adarpoonawalla says will hold capacities in bulk form, will progress to fill finished only po… https://t.co/m9W8nwuuAl" createdat="1606137764000" id="1330864358587396096"></div> The vaccine has shown an average of 70% efficacy. Among the two dosage regimes, one showed efficacy of 90% while the other only gave 62% efficacy. In order to figure which one of the two works better for the Indian population will have to wait till mid-December when the results come in from clinical trials being conducted in the country. India and COVAX get preference for Oxford’s COVID-19 vaccine AstraZeneca is targeting to supply 100 million dosages per month, with a total of 400 million dosages by July 2021. SII is currently in the process of committing capacities to India and the World Health Organisation’s (WHO) COVAX facility — bilateral talks with other countries will come later. Poonawalla also revealed that SII would be applying for approval from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) to start giving out the COVID-19 vaccine to the masses. Simultaneously, the company is also trying to get approval from the Drugs Controller General of India (DCGI) in India. Poonawalla is hopeful that SII will obtain an emergency license before the end of the year. SEE ALSO: <a href="https://www.businessinsider.in/science/health/news/oxford-and-astrazeneca-covid-19-vaccine-is-70-effective-and-india-may-authorise-emergency-use-after-uk-nod/articleshow/79365393.cms">Oxford and AstraZeneca COVID-19 vaccine is 70% effective — India may authorise emergency use after UK nod</a> <a href="https://www.businessinsider.in/stock-market/news/indusind-bank-idfc-first-bank-and-jk-bank-stocks-are-soaring-after-rbi-recommendation/articleshow/79363915.cms">IndusInd Bank surges over 4% after RBI committee proposes to increase the cap on promoter stake in private sector banks</a> <a href="https://www.businessinsider.in/tech/apps/news/how-to-earn-money-at-home-from-googles-task-mate/articleshow/79362215.cms">Google is testing ‘Task Mate’ in India, which lets users earn money for doing tasks on their smartphones</a>

The Oxford COVID-19 vaccine will only cost the Indian government $3 per dose, reveals Adar Poonawalla

<ul class="summary-list"><li>Many large insurers no longer waive COVID-19 treatment costs, <a href="https://www.healthsystemtracker.org/brief/most-private-insurers-are-no-longer-waiving-cost-sharing-for-covid-19-treatment/">a new analysis</a> found.</li><li>Insurers started charging again once vaccines became widely available.</li><li>But <keyword id="11916945" type="UNKNOWN" weightage="60" keywordseo="hospitalizations" source="Orion">hospitalizations</keyword> are rising in the US. Those hospitalized with COVID-19 may pay $1,300, on average.</li></ul>A year ago, around 88% of people enrolled in private health plans through their employers would have had their treatment costs waived had they gotten COVID-19.That's according to an <a href="https://www.healthsystemtracker.org/brief/cost-sharing-waivers-and-premium-relief-by-private-plans-in-response-to-covid-19/">analysis</a> from the Kaiser Family Foundation. But now, most people who get hospitalized with COVID-19 could wind up with a hefty bill. A <a href="https://www.healthsystemtracker.org/brief/most-private-insurers-are-no-longer-waiving-cost-sharing-for-covid-19-treatment/">new report</a> from the same group found that among the two largest insurers in each US state, 72% no longer waive costs for COVID-19 treatment.KFF calculated that the average patient hospitalized with pneumonia (which requires a similar treatment to COVID-19) winds up responsible for around $1,300 in out-of-pocket costs - assuming they have an employer-provided plan.The US government requires private insurers to make COVID-19 tests and vaccines free to the public, but treatments were never part of that mandate. So some states - Massachusetts, New Mexico, Idaho, Michigan, Minnesota, and Rhode Island - enacted their own requirements that insurers waive out-of-pocket treatment costs.But even in other states, private insurers have covered treatment costs during the pandemic for the most part - either as a courtesy to patients or a preemptive measure in case the federal government mandated it, KFF found.Then in November, insurers started to change course. By April 2021, roughly half of the 102 large health plans that KFF examined had stopped waiving COVID-19 treatment costs. Now, just 29 of those plans are waiving costs. Ten of those waivers are set to expire by the end of October, and another 12 will likely expire by the end of 2021.<div type="image" title="Louisiana hospital covid" height="4024" width="6048" msid="85515548" hostid="261"></div>The analysis concluded that insurers "may no longer face political or public relations pressure to continue waiving costs for COVID-19 treatment" now that vaccines are widely available.But COVID-19 hospitalizations are skyrocketing again in the US: On average, daily hospitalizations have risen seven-fold in the last two months, from around 1,600 per day to 11,700 per day. That's similar to levels recorded in February, before vaccines were widely available.Hospitals are now <a href="https://www.businessinsider.com/louisiana-hospital-capacity-failure-covid-2021-8">approaching capacity</a> in Kentucky, Louisiana, and Georgia, among several other states. Alabama has run out of ICU beds. Healthcare workers say they're delaying non-emergency surgeries and denying patient transfers. Some patients have had to wait hours to be admitted to the emergency room. If hospitals become completely full, doctors may have to start turning people away, in some cases determining who lives and who dies.The Delta variant has made severe disease more likely for unvaccinated Americans, who represent the vast majority of COVID-19 hospitalizations. The KFF analysis found that COVID-19 hospitalizations among unvaccinated people cost the US health system $2.3 billion in June and July of this year alone.

Large insurers have stopped waiving COVID-19 treatment costs, an analysis found. Hospitalization could cost you thousands.

<ul class="summary-list"><li>The US <keyword id="6354954" type="UNKNOWN" weightage="60" keywordseo="air-force" source="Orion">Air Force</keyword> said four cadets refused to get vaccinated last week and risked not graduating.</li><li>One person changed their mind and got the vaccine, and will graduate and be commissioned. </li></ul>Three graduating cadets with the US Air Force won't be commissioned as military officers after refusing to get vaccinated for COVID-19, the <a href="https://apnews.com/article/covid-health-united-states-government-and-politics-education-c8debc71373ab4b4390980b12072ef5a">Associated Press</a> reported. "They will not be commissioned into the United States Air Force as long as they remain unvaccinated," Spokesman Dean Miller told the AP. The three cadets will still graduate with a bachelors degree. The Air Force Academy did not immediately respond to Insider's request for comment, but Miller told the AP that a fourth cadet, who initially refused a vaccine, did get the vaccine and will graduate and be commissioned. Miller added that the secretary of the Air Force will decide if the three cadets need to reimburse the US for their educational costs. Air Force officials initially told the <a href="https://apnews.com/article/covid-health-graduation-lloyd-austin-748ecd1d5f9bb5977d0bc3ea7aa4f616">AP</a> last week that the four cadets may not graduate and may owe tuition costs. The costs can add up to more than $200,000. Last year, the Department of Defense <a href="https://www.businessinsider.com/dod-stands-by-vaccine-mandate-national-guard-oklahoma-refusal-2021-11">mandated that all US service members receive the COVID-19</a> vaccine.

You Searched For "covid vaccine cost" and got 8 results

If the COVID-19 vaccine prices are too high for some, then why not use direct benefit transfer

Sriram Iyer

Co-WIN app to be used for COVID-19 vaccine — how to register, documents required, and everything you need to know

Rounak Jain

We're getting closer to an effective COVID-19 vaccine. Here's what it will cost to get a shot.

Shelby Livingston

COVID-19 vaccination for senior citizens to start from March 1 in India — will be free at government hospitals

Prabhjote Gill

The University of Southern Mississippi is paying tuition and housing for some vaccinated students to encourage them to get the shot

Kelsey Vlamis

The Oxford COVID-19 vaccine will only cost the Indian government $3 per dose, reveals Adar Poonawalla

Prabhjote Gill

Large insurers have stopped waiving COVID-19 treatment costs, an analysis found. Hospitalization could cost you thousands.

Aria Bendix

3 Air Force cadets won't be commissioned as officer after refusing to get vaccinated against COVID-19

Sarah Al-Arshani

Popular Keywords

Buying Guides